Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients

Validation of ERCC1-XPF Immunodetection – Letter

(2010) Ken André Olaussen et al.   CANCER RESEARCH

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunodetection of DNA Repair Endonuclease ERCC1-XPF in Human Tissue

(2009) N. R. Bhagwat et al.   CANCER RESEARCH

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

(2009) Craig Reynolds et al.   JOURNAL OF CLINICAL ONCOLOGY

ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen

(2008) J Wei et al.   BRITISH JOURNAL OF CANCER

Platinum Resistance: The Role of DNA Repair Pathways

(2008) L. P. Martin et al.   CLINICAL CANCER RESEARCH

Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial

(2008) Michael S. Braun et al.   JOURNAL OF CLINICAL ONCOLOGY

Systemic Therapy for Biliary Tract Cancers

(2008) A. F. Hezel et al.   ONCOLOGIST